Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2023 08:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery Platform

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced achievement of its device...
August 14, 2023 16:01 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results

NaviCap™ targeted oral delivery platform on track for September IND filing; achieved successful device function study results in humans with phase 1-ready device BioJet™ systemic oral delivery...
August 03, 2023 08:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platform

SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the issuance of a new patent and...
August 02, 2023 08:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that management will be attending...
July 27, 2023 08:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap™ Targeted Oral Delivery Platform

SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced progress with its latest clinical...
July 17, 2023 06:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update

SAN DIEGO, July 17, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report financial...
July 05, 2023 08:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Continues to Monetize Legacy Diagnostics Assets

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has completed an agreement...
June 28, 2023 08:30 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform

SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has been awarded a group...
June 26, 2023 06:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the American Diabetes Association 83rd Scientific Sessions

SAN DIEGO, June 26, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today shared detailed results from its preclinical...
June 14, 2023 16:05 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces Closing of $8 Million Registered Direct Offering of Common Stock and Warrants Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery (“Biora” or the “Company”), today announced the...